NVO Its CEO just stepped down. It lost its battle against Eli Lilly. It's also facing possible tariffs and Medicare policy change from the US. However, the stock has touched the strong support at 58-60. And its PE ratio is much lower than LLY. Possibly a good chance to buy the dip. I am curious what's gonna happen next.